/Companies

Immune Pharmaceuticals

New York, US

Find your way into Immune Pharmaceuticals

Sign up to see every warm intro you have to Immune Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Immune Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DG
Daniel G. TeperChairman and Chief Executive Officer

Board

RL
Rene LererBoard director
AS
Ana StancicBoard director
DK
Daniel KazadoBoard director
DS
David SidranskyBoard director
IK
Isaac KobrinBoard director

Reported raises · per SEC filings

Form D private placements

$11.7M disclosed across 1 round · 2014

▶$11.7MraisedApr 2014 · 42 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rene LererDirector
  • Ana StancicDirector
  • Daniel KazadoDirector
  • Daniel G. TeperExecutive Officer, Director
  • David SidranskyDirector
  • Isaac KobrinDirector
Offering amount
$11.7M
Amount sold
$11.7M
Sales commissions
$544.6K
Placement agents
Chardan Capital Markets LLC
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Immune Pharmaceuticals?
Immune Pharmaceuticals was founded by Daniel G. Teper.
How much funding has Immune Pharmaceuticals raised?
Immune Pharmaceuticals has disclosed $11.7M raised across 1 round.
Where is Immune Pharmaceuticals headquartered?
Immune Pharmaceuticals is headquartered in New York, US.